DERCOS DS DANDRUFF TREATMENT OBSERVATIONAL STUDY 2022
- Conditions
- Dandruff
- Registration Number
- NCT05989633
- Lead Sponsor
- Cosmetique Active International
- Brief Summary
The aim of this study is to evaluate the satisfaction / tolerance / cosmeticity of Dercos DS
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 5131
- Patients with dandruff or seborrheic dermatitis
- All hair types
- All ethnicities (Asian, Caucasian, Afro-American, African, Hispanic)
- Including patients with specific occlusion habits (for instance veil use at least 8 hours per day, hat use)
- Patients willing to provide written informed consent
- Under 12 years old
- Pregnancy, breast feeding, childbearing potential without adequate contraception, or irregular menstrual cycles.
- History of allergy, anaphylaxis or hypersensitivity to any of the ingredients of Shampoo any of the ingredients of DERCOS ANTI-DANDRUFF normal to oily hair shampoo
- History of allergic contact dermatitis secondary to shampoo, conditioner, mask, and/or leave-in.
- Has any clinical manifestations in the treatment(s) or other disorders that, in the opinion of the investigator, may affect the evaluations or results of the study products.- Inability to stay the study period (56 days +-5 days) without performing any hair/scalp procedure, including coloring, straightening and cutting.
- Inability to attend all study visits and follow treatment regimen
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Erythema Day 56 Scale (0=absence to 4= very severe)
Itching Day 56 Scale (0=absence to 10= very severe)
Tolerance Day 28 scale from 0= none to 5=very tolerated
Irritation Day 56 Scale (0=absence to 4= very severe)
Improvement Day 56 scale from 0= worse to 5=very clearly improved
Impact of dandruff on patient Day 56 Scale from 0=not bothered at all to 5=very bothered
Assessment of hair fiber and quality Day 56 scale from 0=worsened to 4=very improved
Product respect/protects hair fiber Day 56 scale from 0=no, it is now more damaged/dry than before the treatment to 3=Yes, my hair fiber looks/feels better than before the treatment
Desquamation Day 56 Scale (0=absence to 4= very severe)
Area involved Day 56 scale from \<10% to \>90%
Patient global satisfaction Day 56 scale ranging from 0=not satisfied at all to 10=very satisfied
Patient product efficacy satisfaction Day 56 questionnare with scale ranging from 0=completely disagree to 5=completely agree
Global evaluation by investigator Day 56 Scale from 0=not at all satisfactory at all to 4=very satisfactory
Patient product acceptability Day 56 scale ranging from 0=not satisfied at all to 10=very satisfied
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Marta Sar Pormian
🇵🇱Warsaw, Poland